Les temps forts en néphrologie en 2023

Mickaël Bobot,Sandrine Lemoine
DOI: https://doi.org/10.1684/ndt.2024.67
2024-02-01
Néphrologie & Thérapeutique
Abstract:This article aims to summarize the “Quoi de neuf en néphrologie?” session held at the 2023 SFNDT Congress in Liège and sessions focused on updates regarding IgA nephropathy (NIgA) and ANCA-associated vasculitis. The agenda for the nephrology “Quoi de neuf en néphrologie?” session this year was to review key publications from non-nephrology journals, discussing topics such as nephroprotection, treatment of glomerulopathies (IgA and APOL1), clinical trials on arterial hypertension, urinary lithiasis, and other areas of renal physiology, including glomerular filtration rate estimation.
urology & nephrology
What problem does this paper attempt to address?